U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


Jayasuriya Anula (0001822933)
Mailing Address
5150 EL CAMINO REAL, SUITE #A-32
LOS ALTOS CA 94022
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Jaguar Health, Inc. 0001585608 2024-10-08 director
BIOTIME INC
Current Name:Lineage Cell Therapeutics, Inc.		 0000876343 2024-07-01 director


Items 1 - 13

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
A 2024-10-08   Jaguar Health, Inc. 4 A-Award --D 21000.0000 21000.0000 1 0001585608 Stock option (right to buy)
A 2024-07-01   Lineage Cell Therapeutics, Inc. 4 A-Award --D 75000.0000 75000.0000 1 0000876343 Stock Option (Right to Buy)
A 2023-12-29   Lineage Cell Therapeutics, Inc. 4 P-Purchase --D 10000.0000 10000.0000 1 0000876343 Common Shares, no par value
A 2023-08-14   Jaguar Health, Inc. 4 A-Award --D 68568.0000 70286.0000 2 0001585608 Common Stock
A 2023-07-01   Lineage Cell Therapeutics, Inc. 4 A-Award --D 50000.0000 50000.0000 1 0000876343 Stock Option (Right to Buy)
A 2023-07-01   Jaguar Health, Inc. 4 A-Award --D 1718.0000 1718.0000 1 0001585608 Common Stock
D 2023-07-01   Jaguar Health, Inc. 4 A-Award --D 1718.0000 0.0000 3 0001585608 Restricted stock units
D 2023-04-06   Jaguar Health, Inc. 4 A-Award --D 1718.0000 1718.0000 1 0001585608 Restricted stock units
A 2022-07-01   Lineage Cell Therapeutics, Inc. 4 A-Award --D 50000.0000 50000.0000 1 0000876343 Stock Option (right to buy)
A 2021-07-01   Lineage Cell Therapeutics, Inc. 4 A-Award --D 50000.0000 50000.0000 1 0000876343 Stock Option (right to buy)
A 2021-05-04   Lineage Cell Therapeutics, Inc. 4 A-Award --D 90000.0000 90000.0000 1 0000876343 Stock Option (Right to Buy)
- -   Lineage Cell Therapeutics, Inc. 3 - --- 1 - -
- -   Jaguar Health, Inc. 3 - --- 1 - -

http://www.sec.gov/cgi-bin/own-disp

Home | Search Home | Previous Page
Modified: 04/22/2016